BPG is committed to discovery and dissemination of knowledge
Featured Articles
9/20/2026 7:29:53 AM | Browse: 2 | Download: 0
Publication Name World Journal of Experimental Medicine
Manuscript ID 125753
Country United States
Received
2026-07-16 09:44
Peer-Review Started
2026-07-16 09:45
First Decision by Editorial Office Director
Return for Revision
2026-08-10 07:45
Revised
2026-08-12 13:18
Publication Fee Transferred
Second Decision by Editor
2026-09-16 07:45
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-09-16 09:47
Articles in Press
2026-09-16 09:47
Edit the Manuscript by Language Editor
Typeset the Manuscript
2026-09-18 00:10
Publish the Manuscript Online
2026-09-20 03:29
ISSN 2220-315x (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Retrospective Cohort Study
Article Title Real-world outcomes for multiple myeloma patients after apheresis for planned chimeric antigen receptor T-cell therapy
Manuscript Source Invited Manuscript
All Author List Ayrton Bangolo, Sarvarinder Gill, Lili Zhang, Jiahe Zhao, Behzad Amoozgar, Ronit Reich-Slotky, Justin Tran, Tri Vo, Gabby Mariblanca, Xenia Balulescu, Sean Mcknight, Nidhi Patel, Aidan Reed, Sukhmani Kaur, Shalini Subramanian, Julie Katyal, Christo Manikkuttiyil, Morgan Chakov, Alisa Nguyen, Sanjana Pashine, Andre Khalil, Steven Mathew, Ravdeep Gill, Varun Andrews, Philip Ordonez, Benjamin Olson, Marianne Koleng, Rajin Persaud, Hrithik S Saride, Mikhail Dharsi, Romon Thach, Winnie Chen, Mahad Shahid, Simcha Weissman, David Siegel, Harsh Parmar, Noa Biran, David H Vesole and Pooja Phull
Funding Agency and Grant Number
Corresponding Author Ayrton Bangolo, Chief Physician, Department of Hematology and Oncology, John Theurer Cancer Center, 92 2nd Street, Hackensack, NJ 07601, United States. ayrton.bangolo@hmhn.org
Key Words Multiple myeloma; Chimeric antigen receptor T-cell therapy; Apheresis; Real-world data; Bridging therapy; Attrition; Immortal-time bias; Time-dependent analysis; B-cell maturation antigen
Core Tip Among 99 myeloma patients undergoing apheresis for planned chimeric antigen receptor T-cell therapy, 12% progressed or died before manufacturing completed (median 54 days). This attrition disproportionately affected patients with aggressive phenotypes, such as extramedullary disease or plasma cell leukaemia. Because raw survival differences overstate treatment effects due to survival bias during manufacturing, time-dependent analyses are essential. Clinically, these findings highlight the urgent need for shorter manufacturing times, intensified bridging therapy and expedited scheduling for high-risk patients, and standardizing outcome reporting from the date of apheresis.
Publish Date 2026-09-20 03:29
Citation

Bangolo A, Gill S, Zhang L, Zhao J, Amoozgar B, Reich-Slotky R, Tran J, Vo T, Mariblanca G, Balulescu X, Mcknight S, Patel N, Reed A, Kaur S, Subramanian S, Katyal J, Manikkuttiyil C, Chakov M, Nguyen A, Pashine S, Khalil A, Mathew S, Gill R, Andrews V, Ordonez P, Olson B, Koleng M, Persaud R, Saride HS, Dharsi M, Thach R, Chen W, Shahid M, Weissman S, Siegel D, Parmar H, Biran N, Vesole DH, Phull P. Real-world outcomes for multiple myeloma patients after apheresis for planned chimeric antigen receptor T-cell therapy. World J Exp Med 2026; 16(3): 125753

URL https://www.wjgnet.com/2220-315x/full/v16/i3/125753.htm
DOI https://doi.org/10.5493/wjem.125753
Full Article (PDF) WJEM-16-125753-with-cover.pdf
STROBE Statement 125753-STROBE-statement.pdf
Manuscript File 125753_Auto_Edited_001354.docx
Answering Reviewers 125753-answering-reviewers.pdf
Audio Core Tip 125753-audio.m4a
Biostatistics Review Certificate 125753-biostatistics-statement.pdf
Conflict-of-Interest Disclosure Form 125753-conflict-of-interest-statement.pdf
Copyright License Agreement 125753-copyright-assignment.pdf
Signed Informed Consent Form(s) or Document(s) 125753-informed-consent-statement.pdf
Institutional Review Board Approval Form or Document 125753-institutional-review-board-statement.pdf
Peer-review Report 125753-peer-reviews.pdf
Scientific Misconduct Check 125753-scientific-misconduct-check.png
CrossCheck Report 125753-crosscheck-report.pdf